Physician

Himani Pulivarthi, MD

According to 2025 Medicare claims, Himani Pulivarthi, MD (NPI: 1598285793) practices nephrology in the Salisbury, MD market, with the plurality of this provider's patient population coming from Wicomico, MD. This provider's primary affiliated billing organization is PENINSULA NEPHROLOGY ASSOCIATES, PA (NPI: 1811916976; TIN: 521068452) and primary practice location at 21801-5422.

Pulivarthi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,309 traditional Medicare patients, billed 7,687 HCPCS/CPT codes, and received $667,671 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 946 prescription claims across 248 beneficiaries totaling $107,252 in drug costs, led by Jardiance (Empagliflozin). Open Payments data shows 22 records totaling $513. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $2,766 to $107,252. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$334K$668K2022 Medicare payment: $231,311 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $628,730 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $667,671 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20226542,145$231,311
20231,3635,740$628,730
20241,3097,687$667,671

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$54K$107K2017 Drug cost: $2,766 (USD; Tot_Drug_Cst)2018 Drug cost: $10,586 (USD; Tot_Drug_Cst)2019 Drug cost: $4,588 (USD; Tot_Drug_Cst)2020 Drug cost: $12,777 (USD; Tot_Drug_Cst)2021 Drug cost: $106 (USD; Tot_Drug_Cst)2022 Drug cost: $13,463 (USD; Tot_Drug_Cst)2023 Drug cost: $68,036 (USD; Tot_Drug_Cst)2024 Drug cost: $107,252 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20172563$2,766
201831112$10,586
201922106$4,588
20201763$12,777
2021N/R14$106
202272137$13,463
2023226688$68,036
2024248946$107,252

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes374489$131
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more6491,088$93
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes4922,024$92
99457Management using the results of remote vital sign monitoring per calendar month, first 20 minutes203721$39
99458Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes183575$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JardianceEmpagliflozin581,957$36,527
FarxigaDapagliflozin Propanediol22900$16,420
Nifedipine ErNifedipine753,675$1,782
Hydralazine HclHydralazine Hcl1245,430$1,277
Losartan PotassiumLosartan Potassium1035,370$765

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$513AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Himani Pulivarthi, MD?

Tedicare shows public-source Medicare data for Himani Pulivarthi, MD (NPI 1598285793), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Himani Pulivarthi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Himani Pulivarthi, MD?

Himani Pulivarthi, MD is linked to PENINSULA NEPHROLOGY ASSOCIATES, PA (billing NPI 1811916976) in the available physician profile data.

Does Himani Pulivarthi, MD have Open Payments data?

Himani Pulivarthi, MD has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.